Table 2.
Cohort 1-1 (Discontinued Due to the Doctor’s Decision) |
Cohort 1-2 (Discontinued Due to Their Own Decision) |
Cohort 2 (Continuing Treatment) |
|
---|---|---|---|
n | 185 | 22 | 65 |
Diagnosis | |||
Within 1 year | 2 (1.1) | 0 | 6 (9.2) |
Within 3 years | 55 (29.7) | 4 (18.2) | 23 (35.4) |
Within 5 years | 59 (31.9) | 7 (31.8) | 16 (24.6) |
Within 10 years | 47 (25.4) | 5 (22.7) | 13 (20.0) |
More than 10 years | 22 (11.9) | 6 (27.3) | 7 (10.8) |
Number of affected eyes | |||
One | 166 (89.7) | 21 (95.5) | 56 (86.2) |
Both | 19 (10.3) | 1 (4.5) | 9 (13.8) |
Current BCVA of the affected eye (self-reported) | |||
0.01–0.1 (20/2000 to 20/200) | 44 (23.8) | 4 (18.2) | 9 (13.8) |
0.2–0.3 (20/100 to 20/67) | 26 (14.1) | 4 (18.2) | 11 (16.9) |
0.4–0.6 (20/50 to 20/33) | 39 (21.1) | 5 (22.7) | 22 (33.8) |
0.7–1.0 (20/29 to 20/20) | 53 (28.6) | 6 (27.3) | 11 (16.9) |
≥1.2 (≥20/17) | 12 (6.5) | 2 (9.1) | 8 (12.3) |
Not sure | 11 (5.9) | 1 (4.5) | 4 (6.2) |
Difficulties in daily life | |||
Recognizing faces or objects | 21 (11.4) | 4 (18.2) | 8 (12.3) |
Reading books or newspapers | 72 (38.9) | 13 (59.1) | 20 (30.8) |
Driving | 33 (17.8) | 6 (27.3) | 15 (23.1) |
Going out alone | 2 (1.1) | 0 | 3 (4.6) |
Other | 21 (11.4) | 2 (9.1) | 7 (10.8) |
No particular difficulties | 81 (43.8) | 3 (13.6) | 30 (46.2) |
Values are n (%); BCVA, best-corrected visual acuity.